Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2019-10-22
DOI
10.1080/21645515.2019.1678998
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy
- (2019) Juliana Elena Silveira Pratti et al. PLoS Neglected Tropical Diseases
- Designing tuberculosis vaccine efficacy trials – lessons from recent studies
- (2019) Ann M. Ginsberg Expert Review of Vaccines
- Current status and management of canine leishmaniasis in Latin America
- (2019) Mary Marcondes et al. RESEARCH IN VETERINARY SCIENCE
- The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice
- (2019) Marcus Vinícius Alves-Silva et al. Frontiers in Immunology
- Immunization with LJM11 salivary protein protects against infection with Leishmania braziliensis in the presence of Lutzomyia longipalpis saliva
- (2018) Jurema M. Cunha et al. ACTA TROPICA
- Development of a new live attenuated Leishmania major p27 gene knockout: Safety and Immunogenicity evaluation in BALB/c mice
- (2018) Samira Elikaee et al. CELLULAR IMMUNOLOGY
- Vaccine candidates against leishmania under current research
- (2018) Salvador Iborra et al. Expert Review of Vaccines
- A lentiviral vaccine expressing KMP11-HASPB fusion protein increases immune response to Leishmania major in BALB/C
- (2018) Nahid Mortazavidehkordi et al. PARASITOLOGY RESEARCH
- Immunity to LuloHya and Lundep, the salivary spreading factors from Lutzomyia longipalpis, protects against Leishmania major infection
- (2018) Ines Martin-Martin et al. PLoS Pathogens
- Biomarkers of Cutaneous Leishmaniasis
- (2018) Fariborz Bahrami et al. Frontiers in Cellular and Infection Microbiology
- Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis
- (2018) Sayonara M. Viana et al. Frontiers in Microbiology
- Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania
- (2018) Negar Seyed et al. Frontiers in Immunology
- A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika
- (2018) Jesse H. Erasmus et al. MOLECULAR THERAPY
- High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection
- (2018) Gerusa B. Carvalho et al. PARASITOLOGY
- Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice
- (2018) Mosayeb Rostamian et al. PLoS One
- Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
- (2018) Malcolm S. Duthie et al. Frontiers in Immunology
- A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection
- (2017) Mariana Costa Duarte et al. IMMUNOBIOLOGY
- Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies
- (2017) Rory Brito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Vaccine Ingredients: Components that Influence Vaccine Efficacy
- (2017) Aneta Kocourkova et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Recent advances in Leishmania reverse genetics: Manipulating a manipulative parasite
- (2017) Samuel M. Duncan et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major -infected BALB/c mice
- (2017) H. Montakhab-Yeganeh et al. PARASITE IMMUNOLOGY
- Leishmaniasis in humans: drug or vaccine therapy?
- (2017) Masoud Ghorbani et al. Drug Design Development and Therapy
- A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
- (2017) Mohamed Osman et al. PLoS Neglected Tropical Diseases
- Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine
- (2017) Maria Agallou et al. PLoS Neglected Tropical Diseases
- Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and Leishmania
- (2017) Tereza Lestinova et al. PLoS Neglected Tropical Diseases
- Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
- (2017) Zahra Abdossamadi et al. PLoS Neglected Tropical Diseases
- A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
- (2017) Marcus Vinícius Alves-Silva et al. Frontiers in Immunology
- Memory T cells in cutaneous leishmaniasis
- (2016) Nelson D. Glennie et al. CELLULAR IMMUNOLOGY
- DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control
- (2016) A. Kumar et al. PARASITE IMMUNOLOGY
- Possibilities and challenges for developing a successful vaccine for leishmaniasis
- (2016) Saumya Srivastava et al. Parasites & Vectors
- Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display
- (2016) Philipp Kuhn et al. Proteomics Clinical Applications
- Status of vaccine research and development of vaccines for leishmaniasis
- (2016) Portia M. Gillespie et al. VACCINE
- Rationale for selection of developmentally regulated genes as vaccine candidates against Leishmania infantum infection
- (2016) Pedro J. Alcolea et al. VACCINE
- Post-Genomics and Vaccine Improvement for Leishmania
- (2016) Negar Seyed et al. Frontiers in Microbiology
- Combination of In Silico Methods in the Search for Potential CD4+ and CD8+ T Cell Epitopes in the Proteome of Leishmania braziliensis
- (2016) Rafael de Freitas e Silva et al. Frontiers in Immunology
- Cutaneous Leishmaniasis Vaccination: A Matter of Quality
- (2016) Paula Mello De Luca et al. Frontiers in Immunology
- Cutaneous Leishmaniasis: Recent Developments in Diagnosis and Management
- (2015) Henry J. C. de Vries et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Cutaneous Infection withLeishmania majorMediates Heterologous Protection against Visceral Infection withLeishmania infantum
- (2015) Audrey Romano et al. JOURNAL OF IMMUNOLOGY
- Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model
- (2015) A. Katebi et al. MOLECULAR IMMUNOLOGY
- Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of theLeishmania amazonensisexperimental infection
- (2015) B. L. S. Campos et al. PARASITE IMMUNOLOGY
- Identifying vaccine targets for anti-leishmanial vaccine development
- (2014) Shyam Sundar et al. Expert Review of Vaccines
- Exploring the immunome: A brave new world for human vaccine development
- (2014) Anne S. De Groot Human vaccines & immunotherapeutics
- Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
- (2014) W. M. Bogers et al. JOURNAL OF INFECTIOUS DISEASES
- Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines
- (2014) Fatemeh Tabatabaie et al. Jundishapur Journal of Microbiology
- Chronic Parasitic Infection Maintains High Frequencies of Short-Lived Ly6C+CD4+ Effector T Cells That Are Required for Protection against Re-infection
- (2014) Nathan C. Peters et al. PLoS Pathogens
- Lundep, a Sand Fly Salivary Endonuclease Increases Leishmania Parasite Survival in Neutrophils and Inhibits XIIa Contact Activation in Human Plasma
- (2014) Andrezza C. Chagas et al. PLoS Pathogens
- Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
- (2014) Noushin Saljoughian et al. Frontiers in Immunology
- Cluster randomised trial to evaluate the effectiveness of a vaccine against cutaneous leishmaniasis in the Caratinga microregion, south-east Brazil
- (2013) W. Mayrink et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis
- (2013) Laura Ramírez et al. VACCINE
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- A Reverse Vaccinology Approach for the Identification of Potential Vaccine Candidates from Leishmania spp
- (2012) Lijo John et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Vaccine process technology
- (2012) Jessica O. Josefsberg et al. BIOTECHNOLOGY AND BIOENGINEERING
- Vaccine prospects of killed but metabolically activeLeishmaniaagainst visceral leishmaniasis
- (2012) Amrita Das et al. Expert Review of Vaccines
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease
- (2012) M. C. A. BRELAZ et al. PARASITE IMMUNOLOGY
- Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis
- (2012) Vahid Heravi Shargh et al. PARASITOLOGY RESEARCH
- Induction of Protective CD4+ T Cell-Mediated Immunity by a Leishmania Peptide Delivered in Recombinant Influenza Viruses
- (2012) Katherine Kedzierska et al. PLoS One
- Vaccination with L. infantum chagasi Nucleosomal Histones Confers Protection against New World Cutaneous Leishmaniasis Caused by Leishmania braziliensis
- (2012) Marcia W. Carneiro et al. PLoS One
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KSAC, a Defined Leishmania Antigen, plus Adjuvant Protects against the Virulence of L. major Transmitted by Its Natural Vector Phlebotomus duboscqi
- (2012) Regis Gomes et al. PLoS Neglected Tropical Diseases
- Efficient Capture of Infected Neutrophils by Dendritic Cells in the Skin Inhibits the Early Anti-Leishmania Response
- (2012) Flavia L. Ribeiro-Gomes et al. PLoS Pathogens
- T Helper1/T Helper2 Cells and Resistance/Susceptibility to Leishmania Infection: Is This Paradigm Still Relevant?
- (2012) James Alexander et al. Frontiers in Immunology
- Adjuvants for Leishmania vaccines: from models to clinical application
- (2012) Vanitha S. Raman et al. Frontiers in Immunology
- Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
- (2012) Ifeoma Okwor et al. Frontiers in Immunology
- Mechanisms of immunity to Leishmania major infection in mice: The contribution of DNA vaccines coding for two novel sets of histones (H2A–H2B or H3–H4)
- (2011) Javier Carrión COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
- Vaccines for Leishmaniasis: From proteome to vaccine candidates
- (2011) Juliane Schroeder et al. Human vaccines & immunotherapeutics
- Leishmaniasis: complexity at the host–pathogen interface
- (2011) Paul Kaye et al. NATURE REVIEWS MICROBIOLOGY
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- The development and clinical evaluation of second-generation leishmaniasis vaccines
- (2011) Malcolm S. Duthie et al. VACCINE
- Vaccines for the Leishmaniases: Proposals for a Research Agenda
- (2011) et al. PLoS Neglected Tropical Diseases
- Leishmania tarentolae: Utility as an in vitro model for screening of antileishmanial agents
- (2010) Viviana M. Taylor et al. EXPERIMENTAL PARASITOLOGY
- Leishmaniasis vaccines: past, present and future
- (2010) Farrokh Modabber INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis
- (2009) Carlos Eduardo Cardoso Fedeli et al. EXPERIMENTAL PARASITOLOGY
- Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
- (2009) Iván D. Vélez et al. VACCINE
- Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection
- (2009) Yasuyuki Goto et al. VACCINE
- A detrimental role for IgG and FcgammaR in Leishmania mexicana infection
- (2008) Laurence U. Buxbaum IMMUNOLOGIC RESEARCH
- Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies
- (2008) Ifeoma Okwor et al. IMMUNOLOGIC RESEARCH
- TheLeishmaniaHSP20 Is Antigenic during Natural Infections, but, as DNA Vaccine, It does not Protect BALB/c Mice against ExperimentalL. amazonensisInfection
- (2008) Ana M. Montalvo-Álvarez et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
- Vaccines for leishmaniasis in the fore coming 25 years
- (2008) Clarisa B. Palatnik-de-Sousa VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now